Tim Witney

UCL – University College London UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021).

🚨Amazing opportunity: position available for a new associate/full professor at the FIL @imagingneuroucl.bsky.social @uclbrainscience.bsky.social! Do you have a neuroimaging-focused research program? Get applying! 🚨

www.ucl.ac.uk/work-at-ucl/...

a bunch of balloons are flying in the sky . ALT: a bunch of balloons are flying in the sky .

I have some BIG NEWS to share today!

Today I begin my next adventure as

Chief Editor of Nature Biomedical Engineering!!

(a thread) @natmethods.nature.com @natbiomedeng.nature.com @natureportfolio.nature.com

The community is very fortunate to have an editor like you Rita.

Associate or Senior Editor, Nature Biomedical Engineering Job Title: Associate or Senior Editor, Nature Biomedical Engineering Organization: Nature Portfolio Location: New York, Jersey City, Shanghai or Beijing – Hybrid Working Closing date: August 20, 2025 ...

If you’d like to join me on this journey, NBME is hiring!! This is a fantastically rewarding career that keeps you very much in science. springernature.wd3.myworkdayjobs.com/SpringerNatu...

This is really sad. I’m sorry it is happening, and particularly sorry it is happening to you and your lab.

Thank you for all your support. 🙏🏻

Let’s go!

What is a micro-retirement? Inside the latest Gen Z trend (Fast Company) Gen Z is rethinking retirement—by taking it in mini doses. The rising trend of *micro-retirements* means career professionals are pressing pause for 1-2 weeks every year to avoid burnout and boost well-being. While it's gaining traction (even among non-Gen Z workers), experts warn these breaks could come with long-term financial and career tradeoffs. Is unplugging worth the risk? Here's what to consider before booking your "someday" now.

the zoomers have rebranded vacation

You’re great at it too. Keep going from success to success. Up the foxes!

This is the only one I’m a pedant about. It’s annoying to some, confusing to others, and oddly satisfying for me to write. ;-)

It was a pleasure to obscure your view and awkwardly say how much I liked your work. Or at least say incorrectly how I *used* to like you work. 😬😅😂

Amazing recording of dead ringers tonight, with added comedy bonus @rosieisaholt.bsky.social photobombing us!

Doing something for the first time is painful. After 7 years, my daughter still can’t hold her knife and fork properly. But if you keep at it, the effort pays off.

Design of porous self-assembled homoleptic and heteroleptic Pd2+ cages incorporating silicon-based fluoride acceptors: the way towards nuclear imaging applications Supramolecular self-assembly is a promising tool to develop multifunctional theranostic agents and has recently entered the field of radiochemistry. In this work, lantern-shaped [Pd2L4]4+ metallacages...

Check out our latest study on Pd-cages for dual-modality imaging including cool MS analysis and fancy in ovo PET imaging, doi.org/10.1039/D5QI...
Congrats to Marike Drexler, Luisa Ronga, Ioannis Kanavos, @gmalcantar.bsky.social Daniela Kraus @timwitney.bsky.social! EIC Pathfinder #SMARTdrugs

Huge congratulations Marike!

Couldn’t agree more. But they are killing us academics here in the UK. Such an easy win. What are Labour thinking!?

Biopharma dives into tumor-seeking radioactive drugs - Nature Biotechnology Big pharma and investors are piling into the precision radiation space as the next generation of increasingly potent targeted α-particle therapies promises to destroy cancerous cells with minimum dama...

Big pharma and investors are piling into the precision radiation space as the next generation of increasingly potent targeted α-particle therapies promises to destroy cancerous cells with minimum damage to healthy tissues nature.com/articles/s41...
rdcu.be/em3YY

That’s a turn up for the books! #inspirationalmessage #lifegoals

Great advertising at our local beauty clinic

Biopharma dives into tumor-seeking radioactive drugs Nature Biotechnology - Big pharma and investors are piling into the precision radiation space as the next generation of increasingly potent targeted α-particle therapies promises to destroy...

Extremely honoured to have our work on supramolecular radiopharmaceuticals highlighted in the latest news in Nature Biotechnology!!! Thank you to the EIC Pathfinder SMARTdrugs @timwitney.bsky.social @hollandlab.bsky.social Alex Poot (UMCU) @cicbiogune.bsky.social Jordi Llop ! rdcu.be/emCW6

Simon Cherry sticking it to the man by negotiating his own tariff reduction for total body PET. Awesome keynote @cruk-cityoflondon.bsky.social symposium. 🙏🏻

Cancer research speed dating over lunch at our TME, imaging and translation symposium @cruk-cityoflondon.bsky.social. The room was buzzing.

Over lunch at our TME, Imaging and Translation Symposium we hosted a 'speed dating' session mixing TME experts with imaging specialists and challenging them to help us set the course for this research theme at our Centre. Ably chaired by @timwitney.bsky.social 📯, we look forward to some great ideas!

Amazing imaging data presented at the @cruk-cityoflondon.bsky.social this morning at our TME, imaging and translational symposium. 😍

All ready for the @cruk-cityoflondon.bsky.social TME, Imaging and Translation Symposium today!

We’re hiring. Postdoctoral and PhD positions available in Medicinal Radiochemistry.

Must have high level of skills and experience in synthetic chemistry, with knowledge of radiochemistry, cellular studies, in vivo imaging desirable.

@erc.europa.eu
@snsf-ch.bsky.social
@chemuzhch.bsky.social

More news...

I'm excited to be joining the team at RayzeBio/BMS working in #radiopharmaceuticals development spanning discovery/optimization and into early phase clinical studies!

Stay tuned!

Big news Freddy and sorry to hear this. Looking forward to seeing what’s next for you and your team.

Nuclide Therapeutics in the sun after a very successful strategy day

Another ESMI podcast in the bag. Destroying amyloid with radionuclide therapy? Madness!